• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性细小病毒 B19 感染。

Prenatal parvovirus B19 infection.

机构信息

Department of Obstetrics and Gynaecology, University Hospital Tuebingen, Calwerstrasse 7, 72076, Tuebingen, Germany.

Department of Obstetrics and Prenatal Medicine, University Hospital of Bonn, Bonn, Germany.

出版信息

Arch Gynecol Obstet. 2024 Nov;310(5):2363-2371. doi: 10.1007/s00404-024-07644-6. Epub 2024 Jul 29.

DOI:10.1007/s00404-024-07644-6
PMID:39073431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11485125/
Abstract

Parvovirus B19 (B19V) causes erythema infectiosum, a.k.a., fifth disease. This disease primarily affects children. It is generally self-limiting and subsides after 1-2 weeks. In pregnancy, the virus can cross the placenta and result in a fetal infection. This may lead to severe fetal anemia, hydrops fetalis, a miscarriage, or intrauterine fetal death. The risk of long-term sequelae also appears to be increased. About one-third of pregnant women are not immune to B19V and, therefore, are at risk to contract a primary infection. The seroconversion rate during pregnancy is generally around 1-2%. During a primary infection, maternal-fetal transplacental transmission of B19V occurs in about 30-50% of the cases and the risk of fetal infection increases with advancing gestational age. The risk of severe fetal anemia or hydrops is around 3-4% overall and is around 6-7% if the primary infection occurs before 20 weeks' gestation. Fetal monitoring in women with a primary B19V infection includes regular ultrasound examinations looking for evidence of hydrops fetalis and Doppler measurements of the middle cerebral artery peak velocity. Fetal blood sampling is performed if a significant anemia is suspected and, if such is found, an intrauterine blood transfusion is needed. This article provides an overview of the epidemiology, pathogenesis, clinical manifestations, diagnostic methods, and management of B19V infection during pregnancy.

摘要

细小病毒 B19(B19V)可引起传染性红斑,也称第五病。这种疾病主要影响儿童。通常是自限性的,1-2 周后自行消退。在妊娠期间,病毒可穿过胎盘,导致胎儿感染。这可能导致严重的胎儿贫血、胎儿水肿、流产或宫内胎儿死亡。长期后遗症的风险似乎也增加了。大约三分之一的孕妇对 B19V 没有免疫力,因此有感染原发性感染的风险。孕妇在妊娠期间的血清转化率一般在 1-2%左右。在原发性感染中,母胎间胎盘传播 B19V 的发生率约为 30-50%,随着妊娠周数的增加,胎儿感染的风险增加。严重胎儿贫血或水肿的总风险约为 3-4%,如果原发性感染发生在 20 周妊娠之前,风险约为 6-7%。对原发性 B19V 感染孕妇的胎儿监测包括定期超声检查,以寻找胎儿水肿的证据,以及大脑中动脉峰值速度的多普勒测量。如果怀疑有严重贫血,需要进行胎儿血液取样,如果发现这种情况,需要进行宫内输血。本文概述了妊娠期间 B19V 感染的流行病学、发病机制、临床表现、诊断方法和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/e749f83dd2b2/404_2024_7644_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/68889613ff99/404_2024_7644_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/f3330d4b5c41/404_2024_7644_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/b6814bcf3d80/404_2024_7644_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/677b47612d84/404_2024_7644_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/58b4b4810448/404_2024_7644_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/7696cfd15be7/404_2024_7644_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/e749f83dd2b2/404_2024_7644_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/68889613ff99/404_2024_7644_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/f3330d4b5c41/404_2024_7644_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/b6814bcf3d80/404_2024_7644_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/677b47612d84/404_2024_7644_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/58b4b4810448/404_2024_7644_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/7696cfd15be7/404_2024_7644_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c0/11485125/e749f83dd2b2/404_2024_7644_Fig7_HTML.jpg

相似文献

1
Prenatal parvovirus B19 infection.先天性细小病毒 B19 感染。
Arch Gynecol Obstet. 2024 Nov;310(5):2363-2371. doi: 10.1007/s00404-024-07644-6. Epub 2024 Jul 29.
2
Parvovirus B19 in Pregnancy.妊娠合并细小病毒 B19 感染。
Obstet Gynecol Surv. 2024 May;79(5):281-289. doi: 10.1097/OGX.0000000000001263.
3
Parvovirus B19 in Pregnancy: A Case Review.妊娠细小病毒 B19:病例回顾。
J Midwifery Womens Health. 2021 May;66(3):385-390. doi: 10.1111/jmwh.13254. Epub 2021 Jun 8.
4
Parvovirus B19 infections in pregnancy.妊娠期细小病毒B19感染
Semin Perinatol. 1998 Aug;22(4):309-17. doi: 10.1016/s0146-0005(98)80019-0.
5
Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.孕期急性人细小病毒B19感染后的胎儿发病率和死亡率:1018例前瞻性评估
Prenat Diagn. 2004 Jul;24(7):513-8. doi: 10.1002/pd.940.
6
Parvovirus b19 infection in pregnancy - A review.妊娠合并细小病毒 B19 感染——综述。
Eur J Obstet Gynecol Reprod Biol. 2021 Sep;264:358-362. doi: 10.1016/j.ejogrb.2021.07.046. Epub 2021 Jul 28.
7
Parvovirus B19 infection in pregnancy.孕期细小病毒B19感染
J Obstet Gynaecol Can. 2014 Dec;36(12):1107-1116. doi: 10.1016/S1701-2163(15)30390-X.
8
[Infection with human parvovirus B19 ('fifth disease') during pregnancy: potential life-threatening implications for the foetus].孕期感染人细小病毒B19(“第五病”):对胎儿潜在的危及生命的影响
Ned Tijdschr Geneeskd. 2008 May 24;152(21):1185-90.
9
Serologic study of human parvovirus B19 infection in pregnancy in Japan.日本孕期人细小病毒B19感染的血清学研究。
J Infect. 1999 Jan;38(1):30-5. doi: 10.1016/s0163-4453(99)90026-9.
10
Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis.人类胎儿感染细小病毒B19:孕期母体感染时间、病毒持续存在及胎儿预后
Pediatr Infect Dis J. 2002 Dec;21(12):1133-6. doi: 10.1097/00006454-200212000-00009.

引用本文的文献

1
Congenital Parvovirus B19 During the 2024 European Resurgence: A Prospective Single-Centre Cohort Study.2024年欧洲疫情复发期间的先天性细小病毒B19:一项前瞻性单中心队列研究
Pathogens. 2025 Aug 9;14(8):798. doi: 10.3390/pathogens14080798.
2
Is parvovirus B19 infection upsurge in 2023-2024 associated with adverse pregnancy outcome?2023 - 2024年B19微小病毒感染激增与不良妊娠结局有关吗?
Ultrasound Obstet Gynecol. 2025 Sep;66(3):307-313. doi: 10.1002/uog.29301. Epub 2025 Jul 30.
3
Second trimester soft markers: still worth to be mentioned?

本文引用的文献

1
Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024.2024 年 1 月至 3 月,丹麦孕妇感染细小病毒 B19 与疾病严重程度的流行情况。
Euro Surveill. 2024 Jun;29(24). doi: 10.2807/1560-7917.ES.2024.29.24.2400299.
2
Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic.自 1990 年以来,荷兰的细小病毒 B19 流行病学发生变化,包括在 COVID-19 大流行后再次出现。
Sci Rep. 2024 Apr 26;14(1):9630. doi: 10.1038/s41598-024-59582-7.
3
An Outbreak of Parvovirus B19 in Israel.
孕中期软指标:仍值得一提吗?
Arch Gynecol Obstet. 2025 May;311(5):1233-1240. doi: 10.1007/s00404-025-08021-7. Epub 2025 Apr 9.
4
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012-2024: COVID-19 Pre-Pandemic, Pandemic and Post-Pandemic Trends.2012 - 2024年意大利大都市地区B19型细小病毒感染的流行病学:新冠疫情前、疫情期间和疫情后趋势
J Med Virol. 2025 Mar;97(3):e70296. doi: 10.1002/jmv.70296.
5
Retrospective and Prospective Surveillance and Clinical Presentation of Parvovirus B19 in Veneto, Italy, 2024.2024年意大利威尼托地区B19微小病毒的回顾性与前瞻性监测及临床表现
Microorganisms. 2025 Feb 16;13(2):430. doi: 10.3390/microorganisms13020430.
6
Reproducibility of fetal ultrasound doppler parameters used for growth assessment.用于生长评估的胎儿超声多普勒参数的可重复性。
Arch Gynecol Obstet. 2025 Mar;311(3):669-676. doi: 10.1007/s00404-024-07883-7. Epub 2025 Jan 16.
以色列的细小病毒 B19 爆发。
Viruses. 2023 Nov 16;15(11):2261. doi: 10.3390/v15112261.
4
Intrauterine Blood Transfusion for Parvo B19-Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes.因细小病毒 B19 引起的胎儿贫血的宫内输血:神经影像学表现和长期神经系统结局。
Fetal Diagn Ther. 2023;50(3):206-214. doi: 10.1159/000530993. Epub 2023 May 17.
5
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment.胎儿 NT-proBNP 水平及其在宫内治疗严重贫血期间的变化。
Arch Gynecol Obstet. 2024 Apr;309(4):1341-1351. doi: 10.1007/s00404-023-07006-8. Epub 2023 Mar 26.
6
Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.103 例因微小病毒感染导致严重贫血的胎儿的宫内输血。一项多中心回顾性研究。
Arch Gynecol Obstet. 2023 Jul;308(1):117-125. doi: 10.1007/s00404-022-06712-z. Epub 2022 Aug 2.
7
Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.宫内胎儿输血后的围产结局和中枢神经系统异常:三级中心 17 年经验
Transfusion. 2020 Nov;60(11):2557-2564. doi: 10.1111/trf.16087. Epub 2020 Sep 21.
8
Identification and management of congenital parvovirus B19 infection.先天性细小病毒B19感染的识别与管理
Prenat Diagn. 2020 Dec;40(13):1722-1731. doi: 10.1002/pd.5819. Epub 2020 Sep 30.
9
ISUOG Practice Guidelines: role of ultrasound in congenital infection.国际妇产科超声学会(ISUOG)实践指南:超声在先天性感染中的作用
Ultrasound Obstet Gynecol. 2020 Jul;56(1):128-151. doi: 10.1002/uog.21991. Epub 2020 May 13.
10
Intraperitoneal transfusion for severe, early-onset rhesus disease requiring treatment before 20 weeks of gestation: A consecutive case series.需要在 20 周妊娠前治疗的严重早发型 Rh 同种免疫疾病的腹腔内输血:连续病例系列。
Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:5-7. doi: 10.1016/j.ejogrb.2019.10.027. Epub 2019 Oct 22.